PharmaVoice

JULY 23, 2025

He was also CEO of La Jolla Pharmaceutical Company from 2011 to 2019, leading the development of a blood pressure drug that failed to meet sales expectations. In particular, Tidmarsh said he wants to boost efficiency in reviews and establish more consistency in communication to sponsors working in the “same disease state.”

FDA 174

FDA Pharmaceutical Companies Pharmaceutical Companies Communication 174

Omnicell

JANUARY 10, 2023

There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. Also, in 2011, the U.S. 2006: Congress passed, and President George W. 340B providers expressed significant concern.

Hospitals 96

Hospitals Omnicell Insurance Documentation 96

ISPE

MARCH 7, 2023

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

APRIL 12, 2021

Humans are diverse and communications to engage us need to be inclusive. Page & Page’s Lisa Jane Lishman outlines why communication and the strategies behind it need to be more personal to ensure that people – whoever they are – feel valued and respected. Today, people are culturally, socially, and demographically diverse.

Communication 116

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 116

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Resolution RDC 10/2011. Published 24 March 2011.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 6, 2023

link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceutical companies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. For pharmaceutical companies, purchased goods (e.g.,

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52